Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-12-002016
Filing Date
2012-06-29
Accepted
2012-06-29 16:26:14
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT admp-10k_033112.htm 10-K 773256
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23_1.htm EX-23.1 4115
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31_1.htm EX-31.1 10041
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31_2.htm EX-31.2 10530
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32_1.htm EX-32.1 4036
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32_2.htm EX-32.2 4371
  Complete submission text file 0001387131-12-002016.txt   2385854

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE admp-20120331.xml EX-101.INS 232952
8 XBRL SCHEMA FILE admp-20120331.xsd EX-101.SCH 17723
9 XBRL CALCULATION FILE admp-20120331_cal.xml EX-101.CAL 31965
10 XBRL DEFINITION FILE admp-20120331_def.xml EX-101.DEF 20117
11 XBRL LABEL FILE admp-20120331_lab.xml EX-101.LAB 126522
12 XBRL PRESENTATION FILE admp-20120331_pre.xml EX-101.PRE 83507
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-26372 | Film No.: 12936334
SIC: 2834 Pharmaceutical Preparations